Skip to main content

NUAK2 inhibition for prostate cancer.

Publication ,  Conference
Fu, W; Zhao, M; Schirmer, A; Maravilla, EJ; Yoon, J; You, S; Freedland, SJ; Macias, E
Published in: MOLECULAR CANCER RESEARCH
2020

Duke Scholars

Published In

MOLECULAR CANCER RESEARCH

EISSN

1557-3125

ISSN

1541-7786

Publication Date

2020

Volume

18

Issue

8

Start / End Page

46 / 46

Related Subject Headings

  • Oncology & Carcinogenesis
  • Developmental Biology
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fu, W., Zhao, M., Schirmer, A., Maravilla, E. J., Yoon, J., You, S., … Macias, E. (2020). NUAK2 inhibition for prostate cancer. In MOLECULAR CANCER RESEARCH (Vol. 18, pp. 46–46).
Fu, Weiwei, Megan Zhao, Amelia Schirmer, Erick J. Maravilla, Junhee Yoon, Sungyong You, Stephen J. Freedland, and Everardo Macias. “NUAK2 inhibition for prostate cancer.” In MOLECULAR CANCER RESEARCH, 18:46–46, 2020.
Fu W, Zhao M, Schirmer A, Maravilla EJ, Yoon J, You S, et al. NUAK2 inhibition for prostate cancer. In: MOLECULAR CANCER RESEARCH. 2020. p. 46–46.
Fu, Weiwei, et al. “NUAK2 inhibition for prostate cancer.MOLECULAR CANCER RESEARCH, vol. 18, no. 8, 2020, pp. 46–46.
Fu W, Zhao M, Schirmer A, Maravilla EJ, Yoon J, You S, Freedland SJ, Macias E. NUAK2 inhibition for prostate cancer. MOLECULAR CANCER RESEARCH. 2020. p. 46–46.

Published In

MOLECULAR CANCER RESEARCH

EISSN

1557-3125

ISSN

1541-7786

Publication Date

2020

Volume

18

Issue

8

Start / End Page

46 / 46

Related Subject Headings

  • Oncology & Carcinogenesis
  • Developmental Biology
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis